Presentation Information
[1S03e-04]Development of a 5HT1b agonist for treating deficits in sociability and irritability in autism spectrum disorder
○Anatol Kreitzer1 (1. MapLight Therapeutics)
Keywords:
autism,sociability,irritability,drug development
Password required to view
Abstract password authentication.
A password is required to view the full text of the abstract. Please refer to the member site for the password.
https://membership.jnss.org/C00/login
A password is required to view the full text of the abstract. Please refer to the member site for the password.
https://membership.jnss.org/C00/login